Your browser doesn't support javascript.
loading
Clozapine-related obsessive-compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study.
Parkin, Katherine; Chen, Shanquan; Biria, Marjan; Plaistow, James; Beckwith, Helen; Jarratt-Barnham, Isaac; Segarra, Nuria; Worbe, Yulia; Fineberg, Naomi A; Cardinal, Rudolf N; Robbins, Trevor W; Fernandez-Egea, Emilio.
Afiliação
  • Parkin K; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Chen S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Biria M; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Plaistow J; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
  • Beckwith H; Department of Psychology, University of Cambridge, Cambridge, UK.
  • Jarratt-Barnham I; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Segarra N; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Worbe Y; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Fineberg NA; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Cardinal RN; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
  • Robbins TW; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Fernandez-Egea E; Sorbonne Université, Paris 05, France.
Psychol Med ; 53(7): 2936-2945, 2023 May.
Article em En | MEDLINE | ID: mdl-35469587
ABSTRACT

BACKGROUND:

Obsessive-compulsive symptoms (OCS) are commonly associated with clozapine treatment but are frequently overlooked by clinicians despite their potential impact on patients' quality of life. In this study, we explored whether OCS severity impacted subjective wellbeing and general functioning, independently of depressive and psychotic symptoms.

METHODS:

We used anonymised electronic healthcare records from a large cohort of patients who were treated with clozapine and assessed annually for OCS, wellbeing, general functioning, and psychopathology using standardised scales as part of routine clinical practice. We used statistical mixed linear model techniques to evaluate the longitudinal influence of OCS severity on wellbeing and general functioning.

RESULTS:

A total of 184 patients were included, with 527 face-to-face assessments and 64.7% evaluated three or more times. Different linear mixed models demonstrated that OCS in patients treated with clozapine were associated with significantly worse wellbeing scores, independently of depression and psychotic symptoms, but OCS did not impair general functioning. Obsessional thinking and hoarding behaviour, but not compulsions, were significantly associated with the impact on wellbeing, which may be attributable to the ego-syntonic nature of the compulsions.

CONCLUSIONS:

Given the frequent occurrence of OCS and their negative impact on wellbeing, we encourage clinicians to routinely assess and treat OCS in patients who are taking clozapine.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Transtorno Obsessivo-Compulsivo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Transtorno Obsessivo-Compulsivo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article